Tirzepatide ODT – Comparable to Mounjaro™ and Zepbound™
Tirzepatide ODT brings the innovation of tirzepatide—the active ingredient in Mounjaro™ and Zepbound™—to a discreet, orally disintegrating tablet.
Tirzepatide is a dual GIP and GLP-1 receptor agonist, giving it a unique advantage in improving blood sugar control and driving significant weight loss. With the ODT format, treatment is simple, portable, and injection-free.
Key Benefits:
• Same active ingredient as Mounjaro™ and Zepbound™
• Dual-action mechanism for enhanced metabolic support
• Promotes weight loss and glycemic control
• Convenient ODT form—dissolves easily on the tongue
• 5mg starting dose for safe and effective initiation
Includes Telehealth Consultation
Each purchase includes a telehealth visit for guidance, monitoring, and personalized treatment.